Literature DB >> 8883422

Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study.

I Harvey1, S Frankel, R Marks, D Shalom, M Nolan-Farrell.   

Abstract

This study aimed to describe the prevalence and incidence of solar keratoses and skin cancers and the natural history of solar keratoses in a random population sample. It was a cross-sectional study, with follow-up, conducted in South Wales, and involved 1034 subjects aged 60 years and over drawn from the Family Health Services Authority register. The main outcome measures were detection of the presence of solar keratoses and skin cancers on sun-exposed skin and photographic validation of solar keratoses and biopsy confirmation of cancers wherever possible. We found that solar keratosis prevalence was 23% (95% confidence interval 19.5-26.5) and that of skin cancer (all types) 2% (95% confidence interval 1.0-3.5). The incidence rate of solar keratoses was 149 lesions per 1000 person-years and of non-melanoma skin cancer 9 per 1000 person-years. In all 21% (95% CL 16-26) of solar keratoses regressed spontaneously during follow-up. None underwent malignant change. We believe that the failure of individuals to seek medical advice and the variable under-registration of non-melanoma skin cancer makes population-based study important. The high prevalence and incidence of malignant and pre-malignant skin lesions in this random sample raise major public health concerns. The high rate of spontaneous regression of solar keratoses and the low rate of malignant change challenges conventional views about the need for routine treatment of these lesions.

Entities:  

Mesh:

Year:  1996        PMID: 8883422      PMCID: PMC2075913          DOI: 10.1038/bjc.1996.534

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  39 in total

1.  Frequency of skin cancer and solar keratoses in a rural southern county as determined by population sampling.

Authors:  Z W Zagula-Mally; E W Rosenberg; M Kashgarian
Journal:  Cancer       Date:  1974-08       Impact factor: 6.860

2.  Genetic predisposition to melanoma and other skin cancers in Australians.

Authors:  M M Brown; C A Sharpe; D S Macmillan; V J McGovern
Journal:  Med J Aust       Date:  1971-04-17       Impact factor: 7.738

3.  The prevalence and accuracy of diagnosis of non-melanotic skin cancer in Victoria.

Authors:  M W Ponsford; G Goodman; R Marks
Journal:  Australas J Dermatol       Date:  1983-08       Impact factor: 2.875

4.  Accuracy of skin cancer incidence data in the United Kingdom.

Authors:  P C Beadle; D Bullock; G Bedford; J F Leach; R A Webb; N A Dent; J L Burton
Journal:  Clin Exp Dermatol       Date:  1982-05       Impact factor: 3.470

5.  Cutaneous malignant melanoma in Rochester, Minnesota: trends in incidence and survivorship, 1950 through 1985.

Authors:  N A Popescu; C M Beard; P J Treacy; R K Winkelmann; P C O'Brien; L T Kurland
Journal:  Mayo Clin Proc       Date:  1990-10       Impact factor: 7.616

6.  Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen.

Authors:  B C Vitasa; H R Taylor; P T Strickland; F S Rosenthal; S West; H Abbey; S K Ng; B Munoz; E A Emmett
Journal:  Cancer       Date:  1990-06-15       Impact factor: 6.860

7.  Non-melanotic skin cancer and solar keratoses in Victoria.

Authors:  R Marks; M W Ponsford; T S Selwood; G Goodman; G Mason
Journal:  Med J Aust       Date:  1983 Dec 10-24       Impact factor: 7.738

8.  Skin cancer epidemiology: research needs.

Authors:  J Scotto; T R Fears
Journal:  Natl Cancer Inst Monogr       Date:  1978-12

9.  The relative importance of risk factors in nonmelanoma carcinoma.

Authors:  P P Vitaliano; F Urbach
Journal:  Arch Dermatol       Date:  1980-04

10.  Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health.

Authors:  A Streetly; H Markowe
Journal:  Int J Epidemiol       Date:  1995-10       Impact factor: 7.196

View more
  17 in total

Review 1.  Basal cell carcinoma.

Authors:  J T Lear; I Harvey; D de Berker; R C Strange; A A Fryer
Journal:  J R Soc Med       Date:  1998-11       Impact factor: 5.344

2.  Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis.

Authors:  Rebecca Gilbert; Chris Metcalfe; Steven E Oliver; David C Whiteman; Chris Bain; Andy Ness; Jenny Donovan; Freddie Hamdy; David E Neal; J Athene Lane; Richard M Martin
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

3.  UVB upregulates the bax promoter in immortalized human keratinocytes via ROS induction of Id3.

Authors:  Valerie Anne Trabosh; Ahmad Daher; Kyle A Divito; Karishma Amin; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal
Journal:  Exp Dermatol       Date:  2008-10-23       Impact factor: 3.960

Review 4.  Skin cancer - an overview for dentists.

Authors:  B J Steel
Journal:  Br Dent J       Date:  2014-05       Impact factor: 1.626

5.  Photoageing skin of the elderly.

Authors:  Sb Khoo
Journal:  Malays Fam Physician       Date:  2010-04-30

6.  A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.

Authors:  Keith Tolley; Danny Kemmett; Signe Thybo; Ruth Nasr; Helen Smethurst
Journal:  Eur J Health Econ       Date:  2015-03-21

7.  Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.

Authors:  Edward C F Wilson
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

8.  Influence of Information Framing on Patient Decisions to Treat Actinic Keratosis.

Authors:  Katherine Berry; Melissa Butt; Joslyn S Kirby
Journal:  JAMA Dermatol       Date:  2017-05-01       Impact factor: 10.282

9.  Validity and Reliability of the Dutch Adaptation of the Actinic Keratosis Quality of Life Questionnaire (AKQoL).

Authors:  Kelly Vis; Rick Waalboer-Spuij; Dyon G C T M Snels; Loes M Hollestein
Journal:  Dermatology       Date:  2018-06-15       Impact factor: 5.366

Review 10.  Health economic evaluation of non-melanoma skin cancer and actinic keratosis.

Authors:  Mitchell K Higashi; David L Veenstra; Paul C Langley
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.